Search
for
Sort by
Research 781–810 of 1000+
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- Wedelolactone, a medicinal plant-derived coumestan, induces caspase-dependent apoptosis in prostate cancer cells via downregulation of PKCε without inhibiting Akt
- The keratoacanthoma: A review
- Trichomegaly of the eyelashes following treatment with cetuximab
- Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I–II feasibility study
- Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients
- Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents
- Scalp reconstruction
- Wedelolactone inhibits breast cancer-induced osteoclastogenesis by decreasing Akt/mTOR signaling
- Coronavirus 2019 Infectious Disease Epidemic: Where We Are, What Can Be Done and Hope For
- Chinese Herbal Medicine for Reducing Chemotherapy-Associated Side-Effects in Breast Cancer Patients: A Systematic Review and Meta-Analysis
- Weekly docetaxel in minimally pretreated cancer patients: A dose-escalation study focused on feasibility and cumulative toxicity of long-term administration
- Minoxidil (Mx) as a prophylaxis of doxorubicin – induced alopecia
- Plasma Dermatology: Skin Therapy Using Cold Atmospheric Plasma
- Cardiovascular Toxicities of Androgen Deprivation Therapy
- Hand-Foot and Stump Syndrome to Sorafenib
- Alopecia in patients treated with molecularly targeted anticancer therapies
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Male pattern baldness and the risk of prostate cancer
- Redefining hormone resistance in prostate cancer
- Acquired hypertrichosis lanuginosa: Case report and review of the literature
- Fatal Toxic Epidermal Necrolysis Associated With Cetuximab in a Patient With Colon Cancer
- Safety and effectiveness of sacituzumab govitecan in patients with metastatic triple-negative breast cancer in real-world settings: first observations from an interdisciplinary breast cancer centre in Germany
- First-in-human phase 1 study of ETC-159 an oral PORCN inhbitor in patients with advanced solid tumours.
- Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022
- Modeling of chronic radiation-induced cystitis in mice
- Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study
- Relationship Between Male Pattern Baldness and the Risk of Aggressive Prostate Cancer: An Analysis of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
- Acquired Hypertrichosis Lanuginosa: A Rare Cutaneous Paraneoplastic Syndrome
- Cutaneous toxicities of new treatments for melanoma